ACCESS Newswire
02 Apr 2020, 17:13 GMT+10
EATONTOWN, NJ / ACCESSWIRE / April 2, 2020 / American CryoStem Corporation (OTC PINK:CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular products and technologies for the Regenerative and Personalized Medicine industries, today announced that it has that it has entered into a license and collaboration agreement to apply American CryoStem technologies for the development therapy in Duchenne Muscular Dystrophy ('DMD') patients. These include autogolous (the patient's own) cell retrieval, storage, expansion and multiple administrations as well as potential use of the American CryoStem's mesenchymal stem cell product, ATCELL™. RaceMD, is a 501(c)3 charitable organization focused on the urgent development, clinical study and delivery of novel treatments to Duchene Muscular Dystrophy patients. RaceMD investigators will collaborate with CRYO laboratory staff and scientists in the development of an accelerated clinical study protocol to be filed with the US FDA.
Duchene Muscular Dystrophy is a fatal childhood disease affecting about 1 in 3,500 males at birth, and is the most common type of muscular dystrophy.
ATCELL™ the Company's autologous cellular therapy product is an experimental drug currently under review by the US FDA with its filed Investigation New Drug Application entitled: ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed via Intravenous Infusion for the Treatment of Post Concussion Syndrome (PCS) in Retired Military and Athletes (IND File No. 19089).
American CryoStem was selected by RaceMD to co develop the clinical study protocol based upon its existing FDA filings, patent portfolio and extensive experience with the collection, processing, expansion, storage and delivery of autologous stem cell therapies.
For further detailed Corporate or Regenerative Medicine information please visit:
www.americancryostem.com, request by email at [email protected] or
Phone 732-747-1007
This press release may contain forward-looking statements, including information about management's view of American CryoStem Corporation's ('the Company') future expectations, plans and prospects. In particular, when used in the preceding discussion, the words 'believes,' 'expects,' 'intends,' 'plans,' 'anticipates,' or 'may,' and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this press release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of the Company, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by American CryoStem Corporation.
SOURCE: American CryoStem Corporation
Get a daily dose of Tennessee Daily news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Tennessee Daily.
More InformationNEW YORK, New York - U.S. stocks were volatile again Friday as President Donald Trump blasted Federal Reserve chair Jerome Powell for...
BRUSSELS, Belgium - The Europesn Central Bank has slashed official interest rates in the wake of the financial crisis triggered by...
BISMARCK, North Dakota: Federal officials have ordered the company running the Keystone Pipeline to take several safety steps after...
GANAPAVARAM, India/GUAYAQUIL, Ecuador: India's shrimp exporters are facing mounting uncertainty as new U.S. tariffs threaten to disrupt...
NEW YORK, New York - Technology stocks fell sharply Wednesday, dragging down the industrial sector in its wake, as Donald Trump's trade...
ABOARD AIR FORCE ONE/TOKYO: U.S. President Donald Trump reaffirmed his opposition to a foreign takeover of U.S. Steel, casting renewed...
NEW YORK CITY, New York: The helicopter tour company involved in a recent crash that killed a pilot and a visiting family from Spain...
BISMARCK, North Dakota: Federal officials have ordered the company running the Keystone Pipeline to take several safety steps after...
WASHINGTON D. C.: President Donald Trump's administration announced late last week that it would stop all federal education funding...
JAKARTA, Indonesia: Indonesia is preparing a high-level visit to Washington with an ambitious offer to avert steep U.S. tariffs on...
GANAPAVARAM, India/GUAYAQUIL, Ecuador: India's shrimp exporters are facing mounting uncertainty as new U.S. tariffs threaten to disrupt...
ABOARD AIR FORCE ONE/TOKYO: U.S. President Donald Trump reaffirmed his opposition to a foreign takeover of U.S. Steel, casting renewed...